Experimental autoimmune myasthenia gravis in mice expressing human immunoglobulin loci

Journal of Neuroimmunology

Volumn 135, Issue 1-2, 2003, Pages 56-61

  Stassen, Maurice H W ^a   Meng, Fanping ^a   Melgert, Eefje ^b   Machiels, Barbie M ^a   Im, Sin Hyeog ^c   Fuchs, Sara ^c   Gerritsen, Arnout F ^b   Van Dijk, Marc A ^b   Van De Winkel, Jan G J ^b   De Baets, Marc H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Acetylcholine receptor (AChR); Autoimmunity; Monoclonal antibodies; Myasthenia gravis; Transgenic mice

Indexed keywords

ACETYLCHOLINE RECEPTOR MONOCLONAL ANTIBODY; CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; GERM LINE; HYBRIDOMA; IMMUNIZATION; IN VIVO STUDY; LYMPH NODE; MOUSE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 0037311257     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00436-8     Document Type: Article

References (22)

1. Almon R.R., Andrew C.G., Appel S.H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 186:1974;55-57.
2. Berman P.W., Patrick J. Experimental myasthenia gravis. A murine system. J. Exp. Med. 151:1980;204-223.
3. Engel A.G., Lambert E.H., Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin. Proc. 52:1977;267-280.
4. Fishwild D.M., O'Donnell S.L., Bengoechea T., Hudson D.V., Harding F., Bernhard S.L., Jones D., Kay R.M., Higgins K.M., Schramm S.R., Lonberg N. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat. Biotechnol. 14:1996;845-851.
5. Fuchs S., Nevo D., Tarrab-Hazdai R., Yaar I. Strain differences in the autoimmune response of mice to acetylcholine receptors. Nature. 263:1976;329-330.
6. Graus Y.M., van Breda Vriesman P.J., de Baets M.H. Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG). Clin. Exp. Immunol. 92:1993;506-513.
7. Graus Y.F., de Baets M.H., Parren P.W., Berrih-Aknin S., Wokke J., van Breda Vriesman P.J., Burton D.R. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J. Immunol. 158:1997;1919-1929.
8. Heinemann S., Bevan S., Kullberg R., Lindstrom J., Rice J. Modulation of acetylcholine receptor by antibody against the receptor. Proc. Natl. Acad. Sci. U. S. A. 74:1977;3090-3094.
9. Im S.H., Barchan D., Souroujon M.C., Fuchs S. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis. J. Immunol. 165:2000;3599-3605.
10. Kao I., Drachman D.B. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science. 196:1977;527-529.
11. Lang B., Richardson G., Rees J., Vincent A., Newsom-Davis J. Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line. J. Neuroimmunol. 19:1988;141-148.
12. Lennon V.A., Lindstrom J.M., Seybold M.E. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141:1975;1365-1375.
13. Lennon V.A., Seybold M.E., Lindstrom J.M., Cochrane C., Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J. Exp. Med. 147:1978;973-983.
14. Lindstrom J.M., Einarson B.L., Lennon V.A., Seybold M.E. Pathological mechanisms in experimental autoimmune myasthenia gravis: I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J. Exp. Med. 144:1976;726-738.
15. Lonberg N., Taylor L.D., Harding F.A., Trounstine M., Higgins K.M., Schramm S.R., Kuo C.C., Mashayekh R., Wymore K., McCabe J.G., Munoz-O'Regan D., O'Donnell S.L., Lapachet E.S.G., Bengoechea T., Fishwild D.M., Carmack C.C., Kay R.M., Huszar D. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature. 368:1994;856-859.
16. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 180:1973;871-872.
17. Raju R., Zhan W.Z., Karachunski P., Conti-Fine B., Sieck G.C., David C. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis. J. Immunol. 160:1998;4169-4174.
18. Schonbeck S., Padberg F., Hohlfeld R., Wekerle H. Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis. J. Clin. Invest. 90:1992;245-250.
19. Toyka K.V., Drachman D.B., Pestronk A., Kao I. Myasthenia gravis: passive transfer from man to mouse. Science. 190:1975;397-399.
20. Tzartos S.J., Sophianos D., Efthimiadis A. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. A Fab monoclonal antibody protects against antigenic modulation by human sera. J. Immunol. 134:1985;2343-2349.
21. Verschuuren J.J., Spaans F., De Baets M.H. Single-fiber electromyography in experimental autoimmune myasthenia gravis. Muscle Nerve. 13:1990;485-492.
22. Verschuuren J.J., Graus Y.M., Theunissen R.O., Yamamoto T., Vincent A., van Breda Vriesman P.J., De Baets M.H. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 36:1992;117-125.